A vial label alone cannot establish whether a peptide is fit for controlled laboratory work. Fragment 176-191 research reagent specifications should give researchers a clear basis for confirming identity, assessing analytical quality, planning handling conditions, and documenting material used in an experiment. For a short synthetic peptide, details that appear minor – salt form, net peptide content, storage history, or the test method behind a purity result – can materially affect consistency across runs.

Fragment 176-191 is generally identified as a 16-amino-acid sequence corresponding to residues 176 through 191 of human growth hormone. In research catalogs, it may also be referenced by its sequence, YLRIVQCRSVEGSCGF, or by alternative compound naming conventions. Names are useful search terms, but they are not a complete specification. A purchase decision should rest on the complete product record and the analytical documentation associated with the specific lot.

What a complete Fragment 176-191 specification includes

A credible research-reagent listing starts with unambiguous identity. The product name should be accompanied by the amino-acid sequence and, where applicable, a molecular formula and expected molecular weight. Fragment 176-191 is commonly associated with a molecular formula of C78H123N23O23S2 and an approximate molecular weight of 1815.1 g/mol for the free peptide. Those figures can change when the material is supplied as an acetate, trifluoroacetate, hydrochloride, or other salt form, so researchers should avoid treating a single molecular-weight figure as universally applicable.

The specification should also distinguish gross vial weight from actual peptide content. Lyophilized peptides can include counterions, residual water, and trace process-related materials. A vial marketed at a stated milligram format may refer to total lyophilized material, net peptide content, or a labeled nominal amount. For experiments that require careful mass balance or concentration calculations, this distinction is central rather than cosmetic.

A well-prepared product page or certificate should make it possible to identify the lot number, fill amount, storage recommendation, and test results tied to that lot. If these elements cannot be connected, the researcher has less ability to reproduce the work later or investigate an unexpected result.

Identity testing: sequence first, label second

The most useful identity evidence for a synthetic peptide is mass spectrometry. A mass result consistent with the expected molecular species provides a direct check that the intended peptide has been produced. For Fragment 176-191, the analytical record should state the observed mass or a result consistent with the expected mass, while accounting for the stated salt form and common ion adducts.

High-performance liquid chromatography, often listed as HPLC, serves a different purpose. It separates peptide-related components and can indicate whether the principal peak is predominant under the stated method. HPLC alone does not fully prove sequence identity, and mass spectrometry alone does not fully describe chromatographic purity. Together, they provide a more useful analytical picture.

When reviewing a certificate of analysis, confirm that the compound name, lot number, analytical date, and result fields correspond to the vial or batch under consideration. A generic sample chromatogram may illustrate a method, but it is not a substitute for lot-specific documentation. Researchers working under formal quality systems may also need to retain the certificate, vial label, receipt, and receiving record as part of their experiment file.

How to read a purity claim

A stated purity percentage needs context. For peptides, the figure is commonly derived from peak area by HPLC or UPLC under a defined detection wavelength and gradient method. It is a useful indicator of chromatographic composition, but it is not automatically an assay of net peptide content, biological activity, sterility, or absence of every possible impurity.

For example, a material with a high reported HPLC purity can still require careful interpretation if the counterion, moisture level, or peptide-content assay is unknown. Conversely, the appropriate purity threshold depends on the experiment. Early analytical screening may have different requirements than a study relying on highly controlled quantitative comparisons. The correct standard is determined by the method, the endpoint, and the tolerance for variability.

Vial format, salt form, and concentration planning

Milligram-based vial formats simplify ordering, but researchers should calculate solutions from verified material information rather than assumptions. Before any reconstitution planning, confirm the labeled amount, peptide form, expected molecular weight, intended final concentration, and solvent compatibility with the experimental method.

Salt form deserves special attention. Synthetic peptides are frequently supplied with a counterion introduced during purification or lyophilization. That counterion may affect the reported mass, pH behavior, and calculation of active peptide equivalents. It can also matter in sensitive analytical systems. A specification that names the salt form gives the laboratory a stronger starting point for method development and documentation.

Solubility is similarly method-dependent. A solvent that works well for one peptide lot or one assay format may not be appropriate for another procedure. The peptide sequence includes charged and sulfur-containing residues, which can influence solution behavior. Small-scale compatibility checks, appropriate controls, and observation for visible particulates or changes after storage are practical safeguards. Do not infer a universal solvent protocol from a product format alone.

Handling and storage specifications that protect the material

Lyophilized peptides generally benefit from cool, dry, light-protected storage, but the supplier’s labeled condition should control. Temperature excursions, repeated opening of the vial, moisture exposure, and prolonged storage after reconstitution can introduce avoidable variables. For traceable research, record the date received, condition on arrival, lot number, storage location, and each reconstitution event.

After reconstitution, aliquoting can reduce repeated freeze-thaw exposure when the experimental plan permits it. The suitable aliquot size depends on expected use frequency and the sensitivity of the assay. It is better to design this decision around actual workflow than to create excessive small aliquots that complicate sample tracking.

Researchers should also differentiate between a material that is analytically suitable at receipt and a solution that remains suitable after days or weeks in a specific matrix. Stability after reconstitution depends on concentration, solvent, container surface, temperature, light exposure, and handling. If the study relies on extended solution storage, verify stability within that exact experimental setup instead of relying solely on dry-vial specifications.

A practical acceptance check before experimental use

The strongest receiving process is concise and repeatable. Begin by inspecting the outer packaging and vial for damage, confirming that the lot number matches the accompanying documentation, and recording the labeled fill amount and storage conditions. Review the certificate for identity testing and chromatographic purity, then determine whether the available information meets the acceptance criteria for the planned work.

Next, preserve a controlled record of how the material enters the experiment. That record should identify the lot, date of preparation, solvent system, calculated concentration, storage condition, and any observations during solution preparation. If a result later deviates from expectation, this documentation helps separate a true experimental finding from a material, calculation, or handling variable.

For research buyers comparing products, transparent specifications often provide more value than broad marketing language. A clearly labeled vial, lot-specific analytical data, a stated milligram format, and practical handling information allow a laboratory to make decisions with less uncertainty. PEPTAS SHOP positions laboratory reagents around clear product formats and research-focused quality expectations, giving technically informed buyers a direct route to evaluate the details that matter.

Research-use boundaries remain part of the specification

A complete product review also includes intended-use language. Fragment 176-191 should be handled as a laboratory research reagent and used only within appropriately controlled research settings. Product specifications, purity statements, and analytical records support experimental evaluation; they do not replace method validation, institutional procedures, or the controls required for a specific study.

The best specification is ultimately one that lets the researcher ask better questions before the vial is opened. Verify the identity, understand what the purity number measures, calculate from the stated form, and preserve the lot record. Those habits turn a catalog selection into a more defensible experimental input.